Broker’s call: Ramco Cements (Buy)

BL Chennai Bureau | Updated on: May 24, 2022

YES Securities

Target: ₹1,135 CMP: ₹658.1

The Ramco Cements (TRCL) reported better-than-expected EBITDA/te of ₹924 (beat Yes Sec est. of ₹774) due to higher-than-expected NSR of ₹5,368/te (+2 per cent than Yes Sec est.) and in-line total cost of ₹4,444/te in Q4-FY22.

The extended monsoon and weak demand in the southern region resulted flat y/y volume growth to 3.2MT (miss of 9 per cent to Yes Sec est.) translate in revenue of ₹1,710 crore miss of 7 per cent to Yes Sec est. in Q4-FY22.

For FY22, TRCL posted a volume growth of 11MT (11 per cent y-o-y; Yes Sec est. 11.3MT) with NSR rise of 3 per cent y-o-y resulting in 14 per cent revenue growth, however EBITDA decline by 17 per cent y-o-y as operating cost surged by 26 per cent y-o-y in FY22.

The inflated fuel/diesel cost eroded the EBITDA/te to ₹1,168 decline by 25 per cent y-o-y in FY22, but sequential price hikes and anticipated cost normalisation should uphold the EBITDA/te at ₹1,150 for FY23E.

We trimmed our EBITDA/PAT est. by 30/40 per cent and 16/21 per cent for FY23/24. We believe TRCL to generate healthy operating cash flow of ₹2,660 crore and its fund ongoing capex (₹850 crore) also deleverage its B/S (10 billion) over FY23-24.

This would aid TRCL to lower the Net Debt/EBITDA to 1.2x by FY24E v/s 2.8x FY22. Thus, we retain our BUY recommendation with a TP of ₹1,135 (earlier ₹1,188 on FY23E), valuing the stock at 15x EV/EBITDA on the FY24 estimates.

Published on May 24, 2022
  1. Comments will be moderated by The Hindu editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.

You May Also Like

Recommended for you